Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Histoplasmosis.

L Joseph Wheat1, Carol A Kauffman

  • 1MiraVista Diagnostics, 4444 Decatur Boulevard, Suite 300, Indianapolis, IN 46241, USA. jwheat@miravistalabs.com

Infectious Disease Clinics of North America
|May 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Liver Necrosis in a Patient Receiving Isavuconazole: Making the Case for Therapeutic Drug Monitoring.

Open forum infectious diseases·2026
Same author

Fungal diagnostic stewardship in immunocompromised populations: a focus on molds and dimorphic fungi.

Clinical microbiology reviews·2026
Same author

Performance of Diagnostic Tests for Histoplasmosis Across Clinical Syndromes and Immune Statuses.

Open forum infectious diseases·2025
Same author

Characteristics and Outcomes of Hospitalized Patients with Histoplasmosis: Comparison of Immunocompromised and Non-Immunocompromised Adult Patients.

Journal of fungi (Basel, Switzerland)·2025
Same author

An outbreak of acute pulmonary histoplasmosis after exposure to guano in a hollow tree in Ecuador.

Travel medicine and infectious disease·2025
Same author

Lack of Association Between <i>Histoplasma</i> Urine Antigen Values and Clinical Response in Persons Without HIV.

Open forum infectious diseases·2025
Same journal

Prevention and Control of Clostridioides difficile Infection for the Infectious Diseases Clinician.

Infectious disease clinics of North America·2026
Same journal

Infection Control Strategies to Prevent Emergence and Transmission of Resistant Gram-Negative Bacteria.

Infectious disease clinics of North America·2026
Same journal

Preventing the Spread of Tuberculosis in Health Care Settings.

Infectious disease clinics of North America·2026
Same journal

Threats to Success: Principles of Infection Prevention and Control in Health Care Settings, Part 2: Device and Pathogen Management.

Infectious disease clinics of North America·2026
Same journal

Ventilator-Associated Events: Surveillance and Prevention.

Infectious disease clinics of North America·2026
Same journal

Nosocomial Fungal Infections: Epidemiology, Control Strategies, and Prevention of Candida and Other Yeasts.

Infectious disease clinics of North America·2026
See all related articles

Histoplasmosis diagnosis requires recognizing varied symptoms and understanding test accuracy. Early recognition and treatment are crucial, especially for severe or fatal cases in immunocompromised individuals.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Clinical Medicine

Background:

  • Histoplasmosis is a fungal infection with diverse clinical presentations.
  • While often asymptomatic, it can lead to severe or fatal outcomes.
  • Risk factors include heavy exposure, immune defects, and delayed diagnosis.

Purpose of the Study:

  • To provide an updated clinical review of histoplasmosis.
  • To focus on the recognition, diagnosis, and management of the infection.
  • To inform clinicians on handling this significant fungal disease.

Main Methods:

  • Clinical review of current literature on histoplasmosis.
  • Analysis of diagnostic methods, including their accuracy and limitations.
  • Discussion of management strategies for various presentations.

Related Experiment Videos

Main Results:

  • Histoplasmosis diagnosis relies on clinical recognition and appropriate testing.
  • Understanding the limitations of diagnostic tests is essential for accurate assessment.
  • Prompt and correct management is vital to prevent severe outcomes.

Conclusions:

  • Effective histoplasmosis management hinges on recognizing clinical signs and employing accurate diagnostic tools.
  • Awareness of risk factors and potential severity is critical for patient outcomes.
  • This review offers current insights for clinical practice regarding histoplasmosis.